Advertisement

Copy Number Variation Analysis on Cell-Free Serum DNA

  • Heidi SchwarzenbachEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1909)

Abstract

Genome diversity comprises single nucleotide polymorphisms, deletions, insertions, and duplications. These gains and losses of DNA segments leading to rearrangements of sequences are termed copy number variations (CNVs). CNVs may disrupt genes and/or alter gene dosage and, thereby, have an impact on both protein-coding and noncoding genes. Accordingly, they affect the activity of various signaling pathways and influence the cell phenotype. They are associated with risks for several severe diseases, in particular cancer. In the current chapter, I introduce a rapid profiling method to identify CNVs in circulating, cell-free DNA by multiplex ligation-dependent probe amplification (MLPA). MLPA represents an efficient method for the detection of CNVs among numerous genes on various chromosomal regions in serum.

Key words

Copy number variation Multiplex ligation-dependent probe amplification Cell-free serum DNA Screening Cancer 

References

  1. 1.
    Zarrei M, MacDonald JR, Merico D, Scherer SW (2015) A copy number variation map of the human genome. Nat Rev Genet 16(3):172–183CrossRefGoogle Scholar
  2. 2.
    Bridges CB (1936) The Bar “Gene” a duplication. Science 83(2148):210–211CrossRefGoogle Scholar
  3. 3.
    Mikhail FM (2014) Copy number variations and human genetic disease. Curr Opin Pediatr 26(6):646–652CrossRefGoogle Scholar
  4. 4.
    Barros FF, Powe DG, Ellis IO, Green AR (2010) Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments. Histopathology 56(5):560–572CrossRefGoogle Scholar
  5. 5.
    Liang L, Fang JY, Xu J (2016) Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy. Oncogene 35(12):1475–1482CrossRefGoogle Scholar
  6. 6.
    Walker LC, Wiggins GA, Pearson JF (2015) The role of constitutional copy number variants in breast cancer. Microarrays (Basel) 4(3):407–423CrossRefGoogle Scholar
  7. 7.
    Molparia B, Nichani E, Torkamani A (2017) Assessment of circulating copy number variant detection for cancer screening. PLoS One 12(7):e0180647CrossRefGoogle Scholar
  8. 8.
    Kirkizlar E, Zimmermann B, Constantin T et al (2015) Detection of clonal and subclonal copy-number variants in cell-free DNA from patients with breast cancer using a massively multiplexed PCR methodology. Transl Oncol 8(5):407–416CrossRefGoogle Scholar
  9. 9.
    Xia S, Huang CC, Le M et al (2015) Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls. Lung Cancer 90(1):78–84CrossRefGoogle Scholar
  10. 10.
    Bettegowda C, Sausen M, Leary RJ et al (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6(224):224ra224. https://doi.org/10.1126/scitranslmed.3007094CrossRefGoogle Scholar
  11. 11.
    Hehir-Kwa JY, Pfundt R, Veltman JA (2015) Exome sequencing and whole genome sequencing for the detection of copy number variation. Expert Rev Mol Diagn 15(8):1023–1032CrossRefGoogle Scholar
  12. 12.
    Soave A, Chun FK, Hillebrand T et al (2017) Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective study. Oncotarget 8(34):56398–56407CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Tumor BiologyUniversity Medical Center Hamburg-EppendorfHamburgGermany

Personalised recommendations